Polyneuron

Swiss biotech start-up. We’re using our Antibody-Catch® technology to develop the most accurate treatment of rare autoimmune disorders.

Type

B2b

Founded

2014

Raised

$41M

Follow us

Companies in the same industry

Alexa global traffic share

Twitter followers

Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Add info

Latest funding Show all

$15,281,700

Venture capital (Series A) - 2020

Sofinnova Partners New Enterprise Associates HBM Healthcare Investments AG

$22,600,000

Venture capital (Series A) - 2019

Sofinnova Partners New Enterprise Associates

Team Size

1–10

Employees

Location

Switzerland

Headquarters

$15,281,700 Venture capital (Series A)

$22,600,000 Venture capital (Series A)

$3,109,641 Seed fund

Health

Seed fund

Health Funding